<?xml version='1.0' encoding='utf-8'?>
<document id="28101466"><sentence text="Characterization of the Effect of Drug-Drug Interaction on Protein Binding in Concurrent Administration of Sulfamethoxazol and Diclofenac Sodium Using Bovine Serum Albumin."><entity charOffset="107-122" id="DDI-PubMed.28101466.s1.e0" text="Sulfamethoxazol" /><entity charOffset="127-144" id="DDI-PubMed.28101466.s1.e1" text="Diclofenac Sodium" /><pair ddi="false" e1="DDI-PubMed.28101466.s1.e0" e2="DDI-PubMed.28101466.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28101466.s1.e0" e2="DDI-PubMed.28101466.s1.e1" /></sentence><sentence text="&#10;                        Purpose:&#10;                     This project was aimed to determine the effect of concurrent administration of sulfamethoxazole and diclofenac sodium"><entity charOffset="134-150" id="DDI-PubMed.28101466.s2.e0" text="sulfamethoxazole" /><entity charOffset="155-172" id="DDI-PubMed.28101466.s2.e1" text="diclofenac sodium" /><pair ddi="false" e1="DDI-PubMed.28101466.s2.e0" e2="DDI-PubMed.28101466.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28101466.s2.e0" e2="DDI-PubMed.28101466.s2.e1" /></sentence><sentence text=" &#10;                        Methods:&#10;                     Equilibrium dialysis method was adopted to study different protein binding aspects of sulfamethoxazole and diclofenac sodium"><entity charOffset="142-158" id="DDI-PubMed.28101466.s3.e0" text="sulfamethoxazole" /><entity charOffset="163-180" id="DDI-PubMed.28101466.s3.e1" text="diclofenac sodium" /><pair ddi="false" e1="DDI-PubMed.28101466.s3.e0" e2="DDI-PubMed.28101466.s3.e0" /><pair ddi="false" e1="DDI-PubMed.28101466.s3.e0" e2="DDI-PubMed.28101466.s3.e1" /></sentence><sentence text=" &#10;                        Results:&#10;                     Sulfamethoxazole showed two types of association constants; high affinity constant 29"><entity charOffset="56-72" id="DDI-PubMed.28101466.s4.e0" text="Sulfamethoxazole" /></sentence><sentence text="0±0" /><sentence text="20×106 M-1 with lower number of binding sites of 0" /><sentence text="7±1 and low affinity constant 1" /><sentence text="13±0" /><sentence text="20×106 M-1 with higher number of binding sites of 3" /><sentence text="45±1 at pH 7" /><sentence text="4 and 40 °C temperature" /><sentence text=" Diclofenac sodium showed high affinity constant 33"><entity charOffset="1-18" id="DDI-PubMed.28101466.s12.e0" text="Diclofenac sodium" /></sentence><sentence text="66±0" /><sentence text="20×106 M-1 with lower number of binding sites of 1" /><sentence text="01±1 and low affinity constant 1" /><sentence text="72±0" /><sentence text="20×106 M-1 with higher number of binding sites of 6" /><sentence text="40±1 at the same condition" /><sentence text=" Site specific probe displacement data implied that site-I, warfarin sodium site, was the high affinity site, while site-II, diazepam site, was the low affinity site for these drugs"><entity charOffset="60-75" id="DDI-PubMed.28101466.s19.e0" text="warfarin sodium" /><entity charOffset="125-133" id="DDI-PubMed.28101466.s19.e1" text="diazepam" /><pair ddi="false" e1="DDI-PubMed.28101466.s19.e0" e2="DDI-PubMed.28101466.s19.e0" /><pair ddi="false" e1="DDI-PubMed.28101466.s19.e0" e2="DDI-PubMed.28101466.s19.e1" /></sentence><sentence text=" During concurrent administration, sulfamethoxazole increased the free concentration of diclofenac sodium from 17"><entity charOffset="35-51" id="DDI-PubMed.28101466.s20.e0" text="sulfamethoxazole" /><entity charOffset="88-105" id="DDI-PubMed.28101466.s20.e1" text="diclofenac sodium" /><pair ddi="false" e1="DDI-PubMed.28101466.s20.e0" e2="DDI-PubMed.28101466.s20.e0" /><pair ddi="false" e1="DDI-PubMed.28101466.s20.e0" e2="DDI-PubMed.28101466.s20.e1" /></sentence><sentence text="5±0" /><sentence text="14% to 70" /><sentence text="0±0" /><sentence text="014% in absence and from 22" /><sentence text="5±0" /><sentence text="07% to 83" /><sentence text="0±0" /><sentence text="014% in presence of site-I specific probe" /><sentence text=" Diclofenac sodium also increased the free concentration of sulfamethoxazole from 2"><entity charOffset="1-18" id="DDI-PubMed.28101466.s29.e0" text="Diclofenac sodium" /><entity charOffset="60-76" id="DDI-PubMed.28101466.s29.e1" text="sulfamethoxazole" /><pair ddi="false" e1="DDI-PubMed.28101466.s29.e0" e2="DDI-PubMed.28101466.s29.e0" /><pair ddi="false" e1="DDI-PubMed.28101466.s29.e0" e2="DDI-PubMed.28101466.s29.e1" /></sentence><sentence text="8±0" /><sentence text="07% to 52" /><sentence text="0±0" /><sentence text="14% and from 8" /><sentence text="5±0" /><sentence text="014% to 64" /><sentence text="4±0" /><sentence text="07% in absence and presence of site-I specific probe respectively" /><sentence text=" &#10;                        Conclusion:&#10;                     The study revealed that the concurrent administration of sulfamethoxazole and diclofenac sodium may result drug concentration alteration in blood"><entity charOffset="116-132" id="DDI-PubMed.28101466.s38.e0" text="sulfamethoxazole" /><entity charOffset="137-154" id="DDI-PubMed.28101466.s38.e1" text="diclofenac sodium" /><pair ddi="false" e1="DDI-PubMed.28101466.s38.e0" e2="DDI-PubMed.28101466.s38.e0" /><pair ddi="false" e1="DDI-PubMed.28101466.s38.e0" e2="DDI-PubMed.28101466.s38.e1" /></sentence><sentence text="" /></document>